Registry of Lobbyists

Monthly Communication Report

Return to Sommaire de 12 mois d'activités de lobbying - Association Canadienne Des Libertes Civiles / Canadian Civil Liberties Association

5088-575301

Corporation: GlaxoSmithKline Inc.
Associated registration: 953603-5088-57
Communication date: 2023-08-24
Posted date: 2023-09-15

Designated Public Office Holders who participated in the communication: Jocelyn Milburn, Director, Office of Life Sciences and Biomanufacturing Readiness
Innovation, Science and Economic Development Canada (ISED)

Celine Menard, Director General
Financial Analysis and Oversight Branch, Innovation, Science and Economic Development Canada (ISED)

Eric Bourbonnais, Director, Investment Opportunities
Strategic Innovation Fund, Innovation, Science and Economic Development Canada (ISED)
 
Subject Matter of the communication: Economic Development,  Health
 
Responsible Officer who filed this communication report: Sridhar Venkatesh
 
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication.

The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.
 

Return to Sommaire de 12 mois d'activités de lobbying - Association Canadienne Des Libertes Civiles / Canadian Civil Liberties Association
Date Modified: